Seizert Capital Partners LLC Grows Holdings in Elevance Health, Inc. (NYSE:ELV)

Seizert Capital Partners LLC raised its stake in Elevance Health, Inc. (NYSE:ELV) by 25.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 130,262 shares of the company’s stock after buying an additional 26,033 shares during the period. Elevance Health comprises about 2.2% of Seizert Capital Partners LLC’s investment portfolio, making the stock its 17th biggest position. Seizert Capital Partners LLC’s holdings in Elevance Health were worth $48,054,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently made changes to their positions in ELV. Raelipskie Partnership purchased a new stake in Elevance Health during the third quarter valued at about $26,000. Crews Bank & Trust purchased a new position in shares of Elevance Health during the fourth quarter worth approximately $34,000. Dunhill Financial LLC boosted its stake in shares of Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after purchasing an additional 26 shares in the last quarter. Peterson Financial Group Inc. bought a new position in shares of Elevance Health during the 3rd quarter valued at $44,000. Finally, Financial Perspectives Inc purchased a new position in Elevance Health in the 4th quarter worth $50,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on ELV. Wells Fargo & Company cut their price target on shares of Elevance Health from $483.00 to $478.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Argus reaffirmed a “hold” rating and issued a $405.40 target price on shares of Elevance Health in a research report on Wednesday, January 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $485.00 price objective on shares of Elevance Health in a research report on Friday, January 24th. Truist Financial decreased their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Mizuho cut their price objective on shares of Elevance Health from $585.00 to $505.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $517.03.

Elevance Health Trading Up 0.6 %

ELV opened at $397.68 on Wednesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.50 and a current ratio of 1.45. The company has a market cap of $90.41 billion, a P/E ratio of 15.53, a PEG ratio of 1.18 and a beta of 0.83. The business’s 50-day simple moving average is $388.77 and its 200-day simple moving average is $436.31. Elevance Health, Inc. has a one year low of $362.21 and a one year high of $567.26.

Elevance Health (NYSE:ELV) last posted its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. As a group, equities research analysts expect that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be paid a dividend of $1.71 per share. The ex-dividend date of this dividend is Monday, March 10th. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a yield of 1.72%. Elevance Health’s dividend payout ratio is currently 26.71%.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.